Intermediates for Key Active Pharmaceutical Ingredients (APIs)
BPS can offer a selection of intermediates used for the production of Key APIs, being APIs whose Patent would expire in less than 5 years from today in Europe.
Do not hesitate to contact us to have more details.
Intermediates for Key APIs
API | INTERMEDIATE / INTERMEDIO / INTERMEDI | CAS |
|---|---|---|
| / | Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | 486460-00-8 |
| Dabigatran | Ethyl-3-[[[2-[[(4-Cyanophenyl) Amino] Methyl]-1methyl-1HBenzimidazol-5- Yl] Carbonyl] Pyridine-2-Ylamino] Propionate | 211915-84-3 |
| Dabigatran | N- (4-Cynophenyl)-Glycine | 42288-26-6 |
| Dabigatran | N- [[2-[[[4 [[[(Hexyloxy) Carbonyl] Amino] Iminomethyl] Phenyl] Amino] Methyl]-1-Methyl-1H-Benzimidazol-5-Yl] Carbonyl]-N-2-Pyridinyl-Β-Alanine Ethyl Ester Methane Sulfonate | 872728-81-9 |
| Dabigatran | Ethyl 3-Amino-3-(Pyridin-2-Yl) Propanoate | 103041-38-9 |
| Dabigatran | 4-(Methylamino)-3-Nitrobenzoic Acid | 41263-74-5 |
| Dabigatran | Ethyl-3- (4-Methylamino)-3-Nitro-N-(Pyridin-2-Yl) Benzamido) Propanoate | 429659-01-8 |
| Dabigatran | Ethyl-3-(2-(((4-Carbamimidoyl Phenyl) Amino) Methyl)-1-Methyl-N-(Pyridin-2-Yl)-1-H-Benzo[D] Imidazole-5-Carboxamido) Propanoate. | 429658-95-7 |
| Dronedarone | 2-N-Butyl-3- (4-Hydroxybenzoyl)-5-Nitrobenzofuran | 141645-16-1 |
| Ranolazine | 2-(2-Methoxy Phenoxy Methyl)-Oxirane | 2210-74-4 |
| Ranolazine | 2-Chloro-N-(2,6-Dimethyl Phenyl)-Acetamide | 1131-01-7 |
| Ranolazine | N- (2,6-Dimethylphenyl)-2-(Piperazin-1-Yl) Acetamide | 5294-61-1 |
| Dapoxetine | ((S)-3-Phenyl-beta-alannol HCl | 936499-93-3 |
| Dapoxetine | (S)-3-Amino-3-phenyl-1-propanol hydrochloride | 936499-93-3 |
| Indacaterol | 2(1H)-Quinolinone, 5-(2-bromoacetyl)-8-(phenylmethoxy)- | 100331-89-3 |
| Lacosamide | BOC- D-Serine | 6368-20-3 |
| Lacosamide | O-methyl-N-alpha-[phenylmethoxy]carbonyl]-N-(phenylmethyl)-D-Serinamide | 880468-89-3 |
| Pitavastatin | 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxaldehyde | 121660-37-5 |
| Tianeptine | 3,11-dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine5,5 -dioxide | 26638-66-4 |
| Tianeptine | 7-Amino-heptanoic acid ethyl ester hydrochloride | 29840-65-1 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
| Ticagrelor | / | 1006614-49-8 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride(1:1) | 1156491-10-9 |
| Ticagrelor | 4,6-Dichloro-2-(propylthio)pyrimidine-5-amine | 145783-15-9 |
| Ticagrelor | / | 220352-39-6 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 274693-26-4 |
| Ticagrelor | 2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d] [1,3]dioxol-4-yloxy)ethanol L-Tartaric Acid | 376608-65-0 |
| Ticagrelor | / | 60410-16.4 |
| Ticagrelor | / | 633312-86-4 |
| Vildagliptin, Anagliptin | (S)-1-(2’-Chloroacetyl)pyrrolidine-2-carbonitrile | 207557-35-5 |
| Dabigatran | n-Hexyl chloroformate | 6092-54-2 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d](1,3)dioxol-4-yl)oxy)ethanol, | 274693-26-4 |
| Eltrombopag | 3-Carboxy benzene boronic acid | 25487-66-5 |
| Fluopyram | 2-(3-Chloro-5-(trifluoromethyl) pyridin-2-yl)ethanamine | 658066-44-5 |
| Lapatinib | 2-Formylfuran-5-boronic acid | 27329-70-0 |
| Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl | 898543-06-1 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine（R）-2-hydroxy-2- phenylacetate (1:1) | 376608-71-8 |
| Ticagrelor | 2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d] [1,3]dioxol-4-yloxy)ethanol L-Tartaric Acid | 376608-65-0 |
| Ticagrelor | 4,6-Dichloro-2-(propylthio)pyrimidine-5-amine | 145783-15-9 |
| Ticagrelor | (3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aHcyclopenta[d][1,3]dioxol-4-ol | 155899-66-4 |
| Ticagrelor | 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 |
| Ticagrelor | 1156491-10-9 (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
| Eltrombopag | 3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid | 376592-93-7 |
| Eltrombopag | 2'-hydroxy-3'-nitro-3-biphenylcarboxylic acid | 376591-95-6 |
| Febuxostat | 4-hydroxybenzothioamide | 25984-63-8 |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 |
| Febuxostat | 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161797-99-5 |
| Dabigatran | 3-[(3-amino-4-methylamino-benzoyl)-Pyridin-2-yl-amino]-proponic acid ethyl ester | 212322-56-0 |
| Dabigatran | 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester | 211915-84-3 |
| Dabigatran | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | 211914-50-0 |
| Dabigatran | N-(4-CYANO-PHENYL)-GLYCINE | 42288-26-6 |
| Dronedarone | (2-butyl-5-nitro-3-benzofuranyl)(4-hydroxyphenyl)-Methanone | 141645-16-1 |
| Dronedarone | 2-butyl-5-nitro-Benzofuran | 133238-87-6 |
| Febuxostat | Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methyl thiazole-5-Carboxylate | 161798-01-2 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)- 4-methyl-5-thiazolecarboxylate | 160844-75-7 |
| Lenalidomide | 2,6-Dioxopiperidine-3-ammonium chloride | 24666-56-6 |
| Lenalidomide | Methyl 2-bromomethyl-3-nitrobenzoate | 98475-07-1 |
| Lenalidomide | 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | 827026-45-9 |
| Pirfenidone | 5-Methyl-2(1H)pypridinone | 1003-68-5 |
| Silodosin | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | 239463-85-5 |
| Silodosin | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 160969-03-9 |
| Netupitant | 6-(4-Methylpiperazin-1-yl)-4-(2-methylphenyl)nicotinamide | 342417-01-0 |
| Netupitant | 2-(3,5-bis(trifluoroMethyl)phenyl)-2-Methyl propanoic acid | 289686-70-0 |
| Indacaterol | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 |
| Bilastine | methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate | 1181267-30-0 |
| Bilastine | tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate | 1181267-36-6 |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| Rivaroxaban | 5-Chloro-2-thiophenecarboxylic acid | 24065-33-6 |
| Rivaroxaban | 5-Chlorothiophene-2-carbonyl chloride | 42518-98-9 |
| Rivaroxaban | (S)-(+)-Glycidyl phthalimide | 161596-47-0 |
| Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one HCl | 898543-06-1 |
| Rivaroxaban | 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | 446292-08-6 |
| Dexmedetomidine | 1-(2,3-Dimethylphenyl)ethyl chloride | 60907-88-2 |
| Dabigatran | N-[2-[4-[N-(Hexyloxycarbonyl)amidino] phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester | 211915-06-9 |
| Nilotinib | 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 641569-94-0 |
| Nilotinib | 1-(3-吡啶基)-3-(二甲氨基)-2-丙烯-1-酮1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | 55314-16-4 |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline | 641571-11-1 |
| Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
| Sitagliptin | Sitagliptin phosephate monohydrate | 654671-77-9 |
| Dabigatran | N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-Alanine, ethyl ester | 212322-56-0 |
| Dabigatran | N-[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine, ethyl ester | 211915-84-3 |
| Dabigatran | Warfarin Sodium 2-Hydroxyacetophenone | 118-93-4 |
| Febuxostat | Ethyl 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161797-99-5 |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161798-01-2 |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| Rivaroxaban | (S)(+)-N-(2, 3-Epoxypropyl)phthalimide | 161596-47-0 |
| Rivaroxaban | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| Saxagliptin | (1S, 3S, 5S)-3-(aminocarbonyl)-2-azabicyclo(3.1.0)hexane-2-carboxylic acidtert-butyl ester | 361440-67-7 |
| Saxagliptin | Boc-3-hydroxy-1-adamantyl-d-glycine | 361442-00-4 |
| Silodosin | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | 239463-85-5 |
| Silodosin | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 160969-03-9 |
| Sitagliptin | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
| Sitagliptin | 2,4,5-Trifluorophenylacetic acid | 209995-38-0 |
| Sitagliptin | Repaglinide (S,S')-3-methyl-1-(2-piperidinophenyl)butylamine; N-acetyl-glutamate salt | 219921-94-5 |
| Eltrombopag | Eltrombopag olamine | 496775-62-3 |
| Eltrombopag | 3-Amino-2-Hydroxy-Biphenyl-3-Carboxylic Acid | 376592-93-7 |
| Eltrombopag | 1-(3,4-Dimethylphenyl)-3-Methyl-3-Pyrazolin-5-One | 18048-64-1 |
| Eribulin | Methyl 2-((2R,4as,6S,7R,8S,8as)-7,8-Bis((Tert-Butyldimethylsilyl)Oxy)-6-((S,E)-1-((Tert-Butyldimethylsilyl) Oxy)-3-Iodoallyl)Octahydropyrano[3,2-B]Pyran-2-Yl)Acetate | 157322-83-3 |
| Eribulin | 2-((2S,3S,4R,5R)-5-((S)-2,3-Bis((Tert-Butyldimethylsilyl)Oxy)Propyl)-4-Methoxy-3-(Tosylmethyl) Tetrahydrofuran-2-Yl)Acetaldehyde | 1808153-90-3 |
| Eribulin | 3-((2S,5S)-5-((3R,5R)-3-Hydroxy-6-Iodo-5-Methylhept-6-En-1-Yl)-4-Methylenetetrahydrofuran-2-Yl)Propyl Pivalate | 157322-47-9 |
| Eribulin | 7,11:10,14:21,24:27,31-Tetraepoxy-5H-Cyclohentriaconta[b]furan-5-one, 2-[(2S)-2,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-12,13,15-tris[[(1,1-dimet hylethyl)dimethylsilyl]oxy]-2,3,3a,4,6,7,8,9,10,11,12,13,14,15,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,32a-triacontahydro-18-hydroxy-3-methoxy-29-methyl-23,30-bis(methylene)-,(2R,3R,3aS,7R,10S,11S,12S,13R,14S,15S,16E,18S/R,21S,24S,27S,29R,31R,32aS)- (9CI) | 871360-42-8(R) |
| Eribulin | 7,11:10,14:21,24:27,31-Tetraepoxy-5H-Cyclohentriaconta[b]furan-5-one, 2-[(2S)-2,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]propyl]-12,13,15-tris[[(1,1-dimet hylethyl)dimethylsilyl]oxy]-2,3,3a,4,6,7,8,9,10,11,12,13,14,15,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,32a-triacontahydro-18-hydroxy-3-methoxy-29-methyl-23,30-bis(methylene)-,(2R,3R,3aS,7R,10S,11S,12S,13R,14S,15S,16E,18S/R,21S,24S,27S,29R,31R,32aS)- (9CI) | 871360-43-9(S) |
| Vildagliptin | 7531-52-4 | |
| Bilastine | tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate | 1181267-36-6 |
| Bilastine | methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate | 1181267-30-0 |
| Bilastine | 4-[1-(4,5-DIHYDRO-4,4-DIMETHYL-2-OXAZOLYL)-1-METHYLETHYL]-BENZENEETHANOL | 361382-26-5 |
| Bilastine | 2-PIPERIDIN-4-YL-1H-BENZOIMIDAZOLE | 38385-95-4 |
| Netupitant | N-Methyl-4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)-3-aminopyridine | 290297-25-5 |
| Netupitant | N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide | 342417-04-3 |
| Trabectedin | 5-(2-AMINOETHYL)-2-METHOXYPHENOL | 3213-30-7 |
| Trabectedin | S-((9H-fluoren-9-yl)methyl)-N-((allyloxy)carbonyl)-L-cystein | 182201-77-0 |
| Trabectedin | 2-TERT-BUTYL-1,1,3,3-TETRAMETHYLGUANIDINE | 29166-72-1 |
| Trabectedin | benzyl (7S,11R)-5-(benzyloxy)-4-methyl-8-oxo-7,8,10,11-tetrahydro-6H-7,11-epimino[1,3]dioxolo[4',5':5,6]benzo[1,2-d]oxocine-12-carboxylate | 182201-51-0 |
| Trabectedin | (S)-tert-butyl 2-(((allyloxy)carbonyl)amino)-3-(3,5-bis((tert-butyldimethylsilyl)oxy)-4-methoxyphenyl)propanoate | 200132-74-7 |
| Tafluprost | (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-one | 209861-00-7 |
| Silodosin | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 160969-03-9 |
| Silodosin | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | 239463-85-5 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)-Ethanol (2R,3R)-2,3-dihydroxysuccinate | 376608-65-0 |
| Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine (R)-2-hydroxy-2-phenylacetate | 376608-71-8 |
| Ticagrelor | 2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol | 376608-74-1 |
| Varenicline | 1-(7,8-dinitro-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone | 230615-59-5 |
| Varenicline | 1-(7,8-diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone | 230615-69-7 |
| Varenicline | 2,3,4,5-tetrahydro-1,5-Methano-1H-3-benzazepine,hydrochloride (1:1) | 230615-52-8 |
| Vildagliptin | 3-amino-1-adamantanol | 702-82-9 |
| Vildagliptin | L-Prolinamide | 7531-52-4 |
| Vildagliptin | Amantadine Hydrochloride | 665-66-7 |
| Tafluprost | (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-Cyclopenta[b]furan-2-one | 209861-00-7 |
| Tafluprost | (3aR,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-one | 209861-01-8 |
| Tafluprost | (3aR,4R,5R,6aS)-5-((1-(l1-boranyl)-2l1-diphosphanyl)oxy)-4-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one | none |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride(1:1) | 1156491-10-9 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine（R）-2-hydroxy-2- phenylacetate (1:1) | 376608-71-8 |
| Ticagrelor | 2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d] [1,3]dioxol-4-yloxy)ethanol L-Tartaric Acid | 376608-65-0 |
| Ticagrelor | (3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aHcyclopenta[d][1,3]dioxol-4-ol | 155899-66-4 |
| Ticagrelor | 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 |
| Ticagrelor | 4,6-Dichloro-2-(propylthio)pyrimidine-5-amine | 145783-15-9 |
| Rivaroxaban | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| Rivaroxaban | 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl] -5-oxazolidinyl]methyl]-1Hisoindole-1,3(2H)-dione | 446292-08-6 |
| Rivaroxaban | 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinonehydrochloride | 898543-06-1 |
| Ambrisentan | (S)-2-Hydroxy-3-methoxy-3,3-dipheylpropionic acid | 178306-52-0 |
| Ambrisentan | 2-Hydroxy-3-Methoxy-3,3-diphenylpropanoic acid | 178306-51-9 |
| Ambrisentan | 2-Hydroxy-3-Methoxy-3,3-diphenylpropanoic acid methyl ester | 178306-47-3 |
| Ambrisentan | 4,6-dimethyl-2-(methylsulfonyl)pyrimidine | 35144-22-0 |
| Ambrisentan | L-Phenylglycinamide | 6485-52-5 |
| Lacosamide | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | 880468-89-3 |
| Lenalidomide | Methyl-2-bromethyl-3-nitrobenzoate | 98475-07-01 |
| Lenalidomide | 3-Amino-2,6-Piperidinedione Hydrochloride | 24666-56-6 |
| Lenalidomide | 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yi)piperidine-2,6-dione | 827026-45-9 |
| Pirfenidone | 2-Hydroxy-5-methylpyridine | 1003-68-5 |
| Pitavastatin | tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate | 124752-23-4 |
| Pitavastatin | [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl] -triphenyl-phosphonium bromido | 154057-58-6 |
| Pitavastatin | (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3- quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester | 147489-06-3 |
| Pitavastatin | 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol | 121660-11-5 |
| Pitavastatin | 3-(Bromomethyl)-2-cyclopropyl-4-(4'-fluorophenyl)quinoline | 154057-56-4 |
| Tianeptine | Tianeptine acid | 66981-73-5 |
| Dabigatran | ethyl3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)- 1Hbenzo[d]imidazole-5-carboxamido)propanoate | 211915-84-3 |
| Dabigatran | 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide | 872728-85-3 |
| Dabigatran | ethyl 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino] propanoate | 429658-95-7 |
| Dabigatran | ethyl3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | 211914-50-0 |
| Dabigatran | ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | 211915-06-9 |
| Pitavastatin | (2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol | 121660-11-5 |
| Pitavastatin | 3-(Bromomethyl)-2-cyclopropyl-4-(4'-fluorophenyl)quinoline | 154057-56-4 |
| Pitavastatin | ((2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)diphenylphosphine oxide | 146578-99-6 |
| Pitavastatin | tert-butyl2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | 147489-06-3 |
| Pitavastatin | tert-butyl(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate | 586966-54-3 |
| Pitavastatin | [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphoniumbromido | 154057-58-6 |
| Pitavastatin | 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde | 121660-37-5 |
| Pitavastatin | tert-butyl 2-((4R,6S)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | 154026-95-6 |
| Pitavastatin | tert-butyl 2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate | 124655-09-0 |
| Pitavastatin | tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate | 124752-23-4 |
| Ticagrelor | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | 155899-66-4 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate | 376608-65-0 |
| Ticagrelor | 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 |
| Ticagrelor | 4,6-dichloro-2-(propylthio)pyrimidin-5-amine | 145783-15-9 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy | 376608-71-8 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 376608-75-2 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 274693-26-4 |
| Febuxostat | 4-Hydroxythiobenzamide | 25984-63-8 |
| Febuxostat | Ethyl 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161797-99-5 |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 |
| Febuxostat | Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 161798-03-4 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7 |
| Liraglutide | N-PalMitoyl-L-glutaMic Acid γ-SucciniMidyl-α-tert-butyl Ester | 204521-63-1 |
| Ticagrelor | 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate | 376608-65-0 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium(2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
| Ticagrelor | 4,6-dichloro-2-propylsulfanylpyrimidin-5-amine | 145783-15-9 |
| Eribulin | (1-Bromovinyl) trimethylsilane | 13683-41-5 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 |
| Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine hydrochloride | 1402222-66-5 |
| Saxagliptin | 2 (S)- N- Boc- 3- hydroxyadamantylglycine | 361442-00-4 |
| Bilastine | methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate | 1181267-30-0 |
| Bilastine | 2-(4-(2-hydroxyethyl)phenyl)-2-Methylpropanoic acid | 38385-95-4 |
| Bilastine | 2-piperidin-4-yl-1H-benzoimidazole | 552301-45-8 |
| Eltrombopag | 3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione | 18048-64-1 |
| Eltrombopag | 5-Chloro-2-hydroxy-3-nitro-(1,1-biphenyl)-3-carboxylic acid 5-氯-2-羟基-3-硝基-(1,1-联苯)-3-羧酸 | 376592-58-4 |
| Eltrombopag | 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one | 376592-93-7 |
| Liraglutide | 2-amino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride | 18451-85-9 |
| Prucalopride | 1-(3-methoxypropyl)-4-piperidinamine | 123654-26-2 |
| Prucalopride | 4-amino-5-chloro-2,3-dihydro-7-benzofurancarboxylic acid | 179474-79-4 |
| Sorafenib | 4-Chloro-2-Cyano Pyridine | 19235-89-3 |
| Bilastine | 2-[4-[1-(4,4-dimethyl-5H-oxazol-2yl)-1-methyl-ethyl]phenyl]ethyl 4-methylbenzenesulfonate | 202189-76-2 |
| Dasatinib | 2-Amino-N-(2-chloro-6-methylphenyl)-1, 3-thiazole-5-carboxamide (172-A) | 302964-24-5 |
| Dasatinib | 4,6-Dichloro-2-methylpyrimidine | 1780-26-3 |
| Rivaroxaban | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| Rivaroxaban | 5- Chlorothiophene-2-carbonyl chloride | 42518-98-9 |
| Rivaroxaban | 4-{4-[(5S)-5-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one | 446292-10-0 |
| Rivaroxaban | 2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione | 161596-47-0 |
| Sorafenib | 4-chloro-N-methylpyridine-2-carboxamide | 220000-87-3 |
| Sorafenib | 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide | 284462-37-9 |
| Sunitinib | 5-formyl-2,4-dimethyl,1H-pyrrole-3-carboxylic acid | 253870-02-9 |
| Sunitinib | 5-fluoro-2-oxiindole | 56341-41-4 |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1yl)-5-(trifluoromethyl)aniline | 641571-11-1 |
| Indacaterol | 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | 312753-53-0 |
| Indacaterol | 2-Chloro-5,6-diethyl-2,3-dihydro-1H-indene | |
| Indacaterol | 8-(Benzyloxy)-5-(2-bromoacetyl)quinolin-2(1H)-one | 100331-89-3 |
| Indacaterol | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | 530084-79-8 |
| Febuxostat | Ethyl-2-(4-hydroxyphenyl)-4-methylthiazaole-5-carboxylate [T2] | 161797-99-5 |
| Febuxostat | Ethyl 2-(3-Formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate [T4] | 161798-03-4 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthaizole-5-carboxylate [T5] | 160844-75-7 |
| Tapentadol | (S)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one | 850222-40-1 |
| Pitavastatin | 2-amino-4'-fluorobenzophenone | 3800-06-4 |
| Sitagliptin | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4] triazolo[4,3-a]pyrazinehydrochloride | 762240-92-6 |
| Febuxostat | 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylic acid ethyl ester | 161798-01-2 |
| Dabigatran | ETHYL 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONATE | 212322-56-0 |
| Dabigatran | 4-CYANOPHENYLGLYCINE | 42288-26-6 |
| Dabigatran | ETHYL 3-(2-(((4-CYANOPHENYL) AMINO) METHYL)-1-METHYL-N-(PYRIDINE-2-YL)-1H-BENZO [D] IMIDAZOLE-5-CARBOXAMIDO) PROPANOATE | 211915-84-3 |
| Etravirine | 4-[(4,6-DICHLOROPYRIMIDIN-2-YL) AMINO] BENZONITRILE | 329187-59-9 |
| Nilotinib | BENZOIC ACID, 3-[(AMINOIMINOMETHYL) AMINO]-4-METHYL-, METHYL ESTER, NITRATE | 1025716-99-7 |
| Nilotinib | 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO] BENZOIC ACID | 641569-94-0 |
| Nilotinib | 3-(4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)ANILINE | 641571-11-1 |
| Nilotinib | 3-[(AMINOIMINOMETHYL) AMINO]-4-METHYL BENZOIC ACID METHYL ESTER MONONITRATE | 641569-96-2 |
| Dasatinib | 2-Methyl-4,6-Dichloropyrimidine | 1780-26-3 |
| Febuxostat | Ethyl-4-Methyl-5-Thiazolecarboxylate | 20582-55-2 |
| Nilotinib | 3-Amino-5-Bromobenzotrifluoride | 54962-75-3 |
| Raltegravir | 5-Methyl-1,3,4-oxadiazole-2-carboxylic Acid Potassium Salt | 888504-28-7 |
| Silodosin | 1H-Indole-7-Carbonitrile, 5-[(2R)-2-Aminopyropyl]-1-[(3-Benzyloxy)Propyl]-2,3-Dihydro-(2R,3R)-dihydroxybutanedioate | 239463-85-5 |
| Silodosin | 2-[2-(2,2,2-Trifluoroethoxy)Phenoxy]ethylMethanesulfonamide | 160969-03-9 |
| Tianeptine | / | 26638-53-9 |
| Dabigatran | 2-((4-Cyanophenyl) amino) acetic acid (DART-D) | 42288-26-6 |
| Dabigatran | Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl) benzamido) propanoate (DART-E) | 212322-56-0 |
| Dabigatran | Ethyl 3-(2-(((4-cyanophenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole -5-carboxamido) propanoate oxalate (DART-F) | 211915-84-3 |
| Febuxostat | Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 161798-03-4 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 160844-75-7 |
| Lapatinib | 2-(Methylsulfonyl)ethylamine Hydrochloride | 104458-24-4 |
| Lapatinib | (5-formylfuran-2-yl)boronic acid | 27329-70-0 |
| Lapatinib | N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine | 231278-20-9 |
| Lenalidomide | 3-aminopiperidine-2,6-dione hydrochloride | 2686-86-4 |
| Lenalidomide | Methyl 2-Bromomethyl-3-Nitrobenzoate | 98475-07-01 |
| Nilotinib | 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic acid | 641569-94-0 |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1yl)-5-(trifluoromethyl)aniline | 641571-11-1 |
| Ranolazine | N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide | 5294-61-1 |
| Ranolazine | 2-[(2-methoxyphenoxy)methyl]oxirane | 2210-74-4 |
| Saxagliptin | (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate | 709031-45-8 |
| Saxagliptin | (1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate | 361440-67-7 |
| Saxagliptin | (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid | 361442-00-4 |
| Silodosin | 2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate | 160969-03-9 |
| Silodosin | 3-[5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydroindol-1-yl]propyl benzoate,(2R,3R)-2,3-dihydroxybutanedioic acid | 239463-85-5 |
| Ticagrelor | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
| Ticagrelor | 4,6-dichloro-2-propylsulfanylpyrimidin-5-amine | 145783-15-9 |
| Ticagrelor | 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate | 376608-65-0 |
| Vorapaxar | (3r,3ar,4s,4ar,7r,8ar,9ar)-7-((ethoxycarbonyl)amino)dodecahydro-3-methyl-1-oxonaphtho(2,3-c)f uran -4-carboxylic acid | 900161-13-9 |
| Vorapaxar | [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(Diphenylamino)carbonyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic acid ethyl ester | 900161-12-8 |
| Vorapaxar | [5-(3-fluorophenyl)-pyridin-2-ylmethyl]-phosphonic acid diethyl ester | 380894-77-9 |
| Dasatinib | Ethyl 2-aminothiazole-5-carboxylate | 32955-21-8 |
| Dasatinib | 2-((tert-butoxycarbonyl) amino) thiazole-5-carboxylic acid | 302964-02-9 |
| Dasatinib | 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | 302964-24-5 |
| Dasatinib | N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | 302964-08-5 |
| Lapatinib | 3-Chloro-4-(3-fluorobenzyloxy)aniline | 202197-26-0 |
| Lapatinib | Potassium tetrachloroplatinate(Ⅱ) | 10025-99-7 |
| Lapatinib | (1R,2R)-(-)-1,2-diaminocyclohexane acid | 20439-47-8 |
| Lenalidomide | 3-Amino-2,6-piperidinedione hydrochloride | 2686-86-4; 24666-56-6 |
| Lenalidomide | Methyl 2-bromomethyl-3-nitrobenzoate | 98475-07-1 |
| Rivaroxaban | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| Rivaroxaban | 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]morpholin-3-one hydrochloride | 898543-06-1 |
| Rivaroxaban | (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 |
| Rivaroxaban | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| Febuxostat | 4-hydroxythiobenzamide | 25984-63-8 |
| Febuxostat | Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161797-99-5 |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 |
| Febuxostat | Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 161798-03-4 |
| Febuxostat | Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate | 161798-02-3 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7 |
| Indacaterol | Methyl 5-Acetylsalicylate | 16475-90-4 |
| Micafungin | FR179642 | 168110-44-9 |
| Chlorantraniliprole | 3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid | 500011-86-9 |
| Chlorantraniliprole | 2-Amino-5-chloro-N,3-dimethylbenzamide | 890707-28-5 |
| Maraviroc | 4,4-difluorocyclohexanecarboxylic acid | 122665-97-8 |
| Tolvaptan | 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 160129-45-3 |
| Tolvaptan | 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one | 137982-91-3 |
| Tolvaptan | 1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | 137977-97-0 |
| Tolvaptan | 2-Methyl-4-(2-methylbenzoylamino)benzoic acid | 317374-08-6 |
| Rivaroxaban | 4-(4-aminophenyl)morpholin-3-one | 438056-69-0 |
| Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
| Rivaroxaban | 5-Chloro-2-thiophenecarboxylic acid | 24065-33-6 |
| Sitagliptin | 3-trifluoro methyl-[1,2,4]triazole[4,3-a]piperazine hydrochloride | 762240-92-6 |
| Sitagliptin | (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine | 767340-03-4 |
| Sitagliptin | [[(1,1-dimethylethoxy)carbonyl]amino]-2,4,5-trifluoro-(R)-benzenebutanoic acid | 486460-00-8 |
| Ticagrelor | 1 ( 1 R t r a n s ) - 2 - ( 3 , 4 - d i f l u o ro p h e n y l ) c y c l o p ro pa n e a m i n e hydrochloride | 1156491-10-9 |
| Ticagrelor | 2 ( 1 R , 2 R ) - 2 - ( 3 , 4 - d i f l u o ro p h e n y l ) c y c l o p ro pa n ami n e ( S ) -(carboxylato(phenyl) methyl)holmium | 376608-71-8 |
| Ticagrelor | 3 2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aHcyclopenta[d] [1,3]dioxol-4-yloxy)ethanol L-Tartaric Acid | 155899-66-4 |
| Ticagrelor | 4 ( 3 a R , 4 S , 6 R , 6 a S ) - 6 - A m i n o - 2 , 2 - d i m e t h y l - t e t r a h y d r o -3a Hcyclopenta[d][1,3]dioxol-4-ol | 376608-65-0 |
| Ticagrelor | 5 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 |
| Ticagrelor | 6 4,6-Dichloro-2-(propylthio)pyrimidine-5-amine | 145783-15-9 |
| Pirfenidone | 2-Amino-5-methylpyridine | 1603-41-4 |
| Dabigatran | 4-(Methylamino)-3-nitrobenzoic acid | 66315-15-9 |
| Dabigatran | Ethyl 3-(pyridin-2-ylamino)propanoate | 103041-38-9 |
| Dabigatran | 2-(4-cyanophenylamino)acetic acid | 42288-26-6 |
| Sorafenib | 4-Chloropyridine-2-carbonyl chloride Hydrochloride | 53750-66-6 |
| Sorafenib | Methyl 2-chloropyridine-4-carboxylate | 58481-11-1 |
| Sorafenib | 2-Pyridinecarboxamide,4-chloro-N-methyl- | 220000-87-3 |
| Sorafenib | N-Methyl-4-(4-aminophenoxy)pyridine-2-carboxamide | 284462-37-9 |
| Vildagliptin | N-Boc-L-Prolinamide | 35150-07-3 |
| Vildagliptin | L-Prolinamide | 7531-52-4 |
| / | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
| Deferasirox | 4-Hydrazinobenzoic acid | 619-67-0 |
| Deferasirox | 2-(2-Hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one | 1218-69-5 |
| Lacosamide | D-Serine | 312-84-5 |
| Lacosamide | N-Boc-D-Serine | 6368-20-3 |
| Rivaroxaban | N-Hydroxyethylamine / 2-Anilinoethanol | 122-98-5 |
| Rivaroxaban | 5-Chloro-2-thiophenecarboxylic acid | 24065-33-6 |
| Rivaroxaban | (S)-(+)-glycidyl phthalimide | 161596-47-0 |
| Rivaroxaban | 4-(4-aminophenyl)morpholin-3-one | 438056-69-0 |
| Sitagliptin | 2,4,5-Trifluorophenyl acetic acid | 209995-38-0 |
| Sitagliptin | (R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl) butanoic acid | 486460-00-8 |
| Sitagliptin | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
| Sitagliptin | Sitagliptin phosephate monohydrate | 654671-77-9 |
| Vildagliptin | 3-Amino-1-adamantanol | 702-82-9 |
| Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |
| Vildagliptin | Vildagliptin | 274901-16-5 |
| Deferasirox | 2-(2-Hydroxy phenyl)-4H-benzo[e] [1, 3] oxazin-4-one. | 1218-69-5 |
| Febuxostat | Ethyl 2-(4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate | 161797-99-5 |
| Febuxostat | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-01-2 |
| Febuxostat | Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate | 161798-02-3 |
| Febuxostat | Ethyl-2-(3-Formyl-4-isobutoxy phenyl)-4-methyl-1,3-thiazole-5-carboxylate | 161798-03-4 |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- | 144060-97-9 |
| Prucalopride | 1-(3-Methoxy propyl) piperidine-4-one | 16771-85-0 |
| Rivaroxaban | 4-[4-[(5S)-5-Phthalimidomethyl-2-Oxo-3-Oxazolidinyl]Phenyl]-3-Morpholinone | 446292-08-6 |
| Rivaroxaban | 4-(4-((S)-5-(Aminomethyl)-2-Oxooxazolidin-3-Yl) Phenyl)Morpholin-3-One Hydrochloride | 898543-06-1 |
| Dasatinib | 1780-26-3 | |
| Rivaroxaban | 161596-47-0 | |
| Indacaterol | 173140-90-4 | |
| Vildagliptin | 207557-35-5 | |
| Varenicline | 1-(7,8-diamino-1,2,4,5-tetrahydro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoroethanone | 230615-69-7 |
| Rivaroxaban | 24065-33-6 | |
| Indacaterol | 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 |
| Rivaroxaban | 438056-69-0 | |
| Rivaroxaban | 446292-07-5 | |
| Rivaroxaban | 446292-08-6 | |
| Vildagliptin | 3-amino-1-hydroxyadamantane | 702-82-9 |
| Sitagliptin | 764667-65-4 | |
| Fosaprepitant | 990-91-0 | |
| Febuxostat | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 160844-75-7 |
| Pitavastatin | Pitavastatin tert-Butyl Ester | 147511-69-1 |
| Rivaroxaban | (S)-(+)-Glycidyl Phthalimide | 161596-47-0 |
| Rivaroxaban | 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione | 446292-08-6 |
| Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
| Rivaroxaban | 4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3-morpholinone | 446292-07-5 |
| Rivaroxaban | (R)-4-[4-[(3-Chloro-2-hydroxypropyl)amino]phenyl]morpholin-3-one | 1252018-10-2 |
| Dexamethasone, Betamethasone | 11a-hydroxyandrost-4-ene-3,17-dione | 564-33-0 |
| Rivaroxaban | 161596-47-0 | |
| Rivaroxaban | 24065-33-6 | |
| Rivaroxaban | 438056-69-0 | |
| Rivaroxaban | 446292-07-5 | |
| Rivaroxaban | 446292-08-6 | |
| Rivaroxaban | 898543-06-1 | |
| Vildagliptin | 207557-35-5 | |
| Vildagliptin | 702-82-9 | |
| Tapentadol, Tramadol | Meta Bromo Anisole | 2398-37-0 |
| Vildagliptin | 3-Amino-1-Adamantanol | 702-82-9 |
| Vildagliptin | L-Prolinamide. | 7531-52-4 |
| Sitagliptin | 2,4,5 Trifluorophenylacetic Acid | 209995-38-0 |
| Decitabine, Azacitidine | 4-amino-1,3,5-triazin-2(1H)-one | 931-86-2 |
| Dasatinib | 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | 302964-24-5 |
| Dasatinib | 4,6-dichloro-2-methylpyrimidine | 1780-26-3 |
| Lapatinib | N-[3-Chloro-4-(3-fluorobenzyloxy)-phenyl]-6-iodoquinazolin-4-amine | 231278-20-9 |
| Lapatinib | 2-Formylfuran-5-boronic acid | 27329-70-0 |
| Lenalidomide | methyl 2-(bromomethyl)-3-nitrobenzenecarboxylate | 98475-07-1 |
| Lenalidomide | N-Carbobenzyloxy-L-glutamine | 2650-64-8 |
| Nilotinib | 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | 641569-94-0 |
| Nilotinib | 3-Amino-5-(4-methyl-1H-imidazol-1-yl)benzotrifluoride | 641571-11-1 |
| Dabigatran | 3-([{2-[(4-Cyanophenyl) amino] methyl-1-methyl -1H-benzimidazol-5-yl} carbonyl] pyridin-2-ylamino) propionic acid ethyl ester (DG-4) | 211915-84-3 |
| Dabigatran | Ethyl 3-[{[3-amino-4-(methylamino)phenyl]carbonyl}(pyridin-2-yl)amino]propanoate (DG-3) | 212322-56-0 |
| Dabigatran | Ethyl 3-(pyridine-2-ylamino) propanoate (DGSA) | 103041-38-9 |
| Dabigatran | 2-(4-Cyanophenylamino) acetic acid (DGSB) | 42288-26-6 |
| Eribulin | Propanoic acid, 2,2-dimethyl-, 3-[tetrahydro-5-(3-hydroxy-6-iodo-5-methyl-6-heptenyl)-4-methylene-2-furanyl]propyl ester, [2S-[2α,5β(3S*,5S*)]]- (9CI) | 157322-47-9 |
| Eribulin | D-glycero-D-gulo-Nonose, 3,6-anhydro-2,4,7-trideoxy-8,9-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-5-O-methyl-4-[(phenylsulfonyl)methyl] | 871348-24-2 |
| Eribulin | L-arabino-D-allo-Tridec-12-enonic acid, 3,7:6,10-dianhydro-2,4,5,12,13-pentadeoxy-8,9,11-tris-O- [(1,1-dimethylethyl)dimethylsilyl]-13-iodo-, methyl ester, (12E) | 157322-83-3 |